Polverini to receive IADR Oral Medicine and Pathology Award

June 28, 2006

Dr. Peter Polverini, Professor and Dean of the University of Michigan School of Dentistry (Ann Arbor), has been named the 2006 recipient of the Oral Medicine and Pathology Research Award, conferred by the International Association for Dental Research (IADR), convening here today for its 84th General Session.

A native of Everett, Massachusetts, Dr. Polverini was educated at Marquette University School of Dentistry (Milwaukee, WI), with post-graduate studies at the Harvard Medical School and the Harvard School of Dental Medicine. He has been honored many times for his teaching and research in oral pathology, including the award of the Donald A. Kerr Endowed Professorship at the University of Michigan, and is a Fellow of the American College of Dentists. He has served as member and chair of many NIH Study Sections and served on the editorial board of the International Journal of Oral Biology and the Journal of Oral Medicine and Pathology. He has published extensively on his research into angiogenesis and oral cancer.

The IADR Oral Medicine and Pathology Research Award is supported by Sunstar Butler and consists of a cash prize and a plaque. It is one of 15 Distinguished Scientist Awards given annually by the IADR.

Dr. Polverini receives his award today during the Opening Ceremonies of the IADR's 84th General Session.
-end-


International & American Associations for Dental Research

Related Pathology Articles from Brightsurf:

Aging alone does not explain kidney pathology
Histopathology in non-neoplastic kidney tissue from 1,347 nephrectomy specimens showed very limited histopathologic changes in subset of older individuals.

MarrowQuant: A new digital-pathology tool
EPFL scientists have developed a digital pathology tool for quantifying bone marrow compartments in standard histological sections.

DNA webs may drive lung pathology in severe COVID-19
Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine (JEM).

Novel pathology could improve diagnosis and treatment of Huntington's and other diseases
Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.

Framework helps clinicians identify serious spinal pathology
Rehabilitation clinicians and other health care professionals now have a framework for assessing and managing people who may have serious spinal pathologies.

Subtle decline in cognition predicts progression to Alzheimer's pathology
Researchers at UC San Diego School of Medicine report that abnormal levels of beta-amyloid plaques in brain predict cognitive decline and higher risk of developing Alzheimer's disease, but also that cognitive performance predicts progression from normal to abnormal levels of beta-amyloid.

Metabolic disturbance in the brain exacerbates, may forewarn Alzheimer's pathology
A better understanding of the metabolic processes in the brain -- specifically disturbances resulting from neurodegenerative diseases -- has important implications for potential treatments.

Sleep history predicts late-life Alzheimer's pathology
Sleep patterns can predict the accumulation of Alzheimer's pathology proteins later in life, according to a new study of older men and women published in JNeurosci.

Amyloid pathology transmission in lab mice and historic medical treatments
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Improved understanding of the pathology of dwarfism may lead to new treatment targets
Pseudoachondroplasia (PSACH) is a severe inherited dwarfing condition In PSACH, a genetic mutation leads to abnormal retention of cartilage oligomeric matrix protein (COMP) within the endoplasmic reticulum (ER) of cartilage-producing cells (chondrocytes), which interferes with function and cell viability.

Read More: Pathology News and Pathology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.